Murthy K S, Teng B, Jin J, Makhlouf G M
Departments of Physiology and Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0711, USA.
Am J Physiol. 1998 Dec;275(6):C1409-16. doi: 10.1152/ajpcell.1998.275.6.C1409.
In gastrointestinal smooth muscle, the neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) induce relaxation by interacting with VIP2/PACAP3 receptors coupled via Gs to adenylyl cyclase and with distinct receptors coupled via Gi1 and/or Gi2 to a smooth muscle endothelial nitric oxide synthase (eNOS). The present study identifies the receptor as the single-transmembrane natriuretic peptide clearance receptor (NPR-C). RT-PCR and Northern analysis demonstrated expression of the natriuretic peptide receptors NPR-C and NPR-B but not NPR-A in rabbit gastric muscle cells. In binding studies using 125I-labeled atrial natriuretic peptide (125I-ANP) and 125I-VIP as radioligands, VIP, ANP, and the selective NPR-C ligand cANP(4-23) bound with high affinity to NPR-C. ANP, cANP-(4-23), and VIP initiated identical signaling cascades consisting of Ca2+ influx, activation of eNOS via Gi1 and Gi2, stimulation of cGMP formation, and muscle relaxation. NOS activity and cGMP formation were abolished (93 +/- 3 to 96 +/- 2% inhibition) by nifedipine, pertussis toxin, the NOS inhibitor, NG-nitro-L-arginine, and the antagonists ANP-(1-11) and VIP-(10-28). NOS activity stimulated by all three ligands in muscle membranes was additively inhibited by Gi1 and Gi2 antibodies (82 +/- 2 to 84 +/- 1%). In reconstitution studies, VIP, cANP-(4-23), and guanosine 5'-O-(3-thiotriphosphate) stimulated NOS activity in membranes of COS-1 cells cotransfected with NPR-C and eNOS. The results establish a unique mechanism for G protein-dependent activation of a constitutive NOS expressed in gastrointestinal smooth muscle involving interaction of the relaxant neuropeptides VIP and PACAP with a single-transmembrane natriuretic peptide receptor, NPR-C.
在胃肠平滑肌中,神经肽血管活性肠肽(VIP)和垂体腺苷酸环化酶激活肽(PACAP)通过与经由Gs偶联至腺苷酸环化酶的VIP2/PACAP3受体以及经由Gi1和/或Gi2偶联至平滑肌内皮型一氧化氮合酶(eNOS)的不同受体相互作用来诱导舒张。本研究确定该受体为单跨膜利钠肽清除受体(NPR-C)。逆转录聚合酶链反应(RT-PCR)和Northern分析表明,在兔胃肌细胞中存在利钠肽受体NPR-C和NPR-B的表达,但不存在NPR-A的表达。在使用125I标记的心房利钠肽(125I-ANP)和125I-VIP作为放射性配体的结合研究中,VIP、ANP和选择性NPR-C配体cANP(4-23)与NPR-C具有高亲和力结合。ANP、cANP-(4-23)和VIP引发相同的信号级联反应,包括Ca2+内流、经由Gi1和Gi2激活eNOS、刺激cGMP形成以及肌肉舒张。硝苯地平、百日咳毒素、NOS抑制剂NG-硝基-L-精氨酸以及拮抗剂ANP-(1-11)和VIP-(10-28)可消除(抑制93±3至96±2%)NOS活性和cGMP形成。在肌膜中由所有三种配体刺激的NOS活性被Gi1和Gi2抗体累加抑制(82±2至84±1%)。在重组研究中,VIP、cANP-(4-23)和鸟苷5'-O-(3-硫代三磷酸)刺激与NPR-C和eNOS共转染的COS-1细胞膜中的NOS活性。这些结果确立了一种独特的机制,即胃肠平滑肌中表达的组成型NOS通过G蛋白依赖性激活,涉及舒张性神经肽VIP和PACAP与单跨膜利钠肽受体NPR-C的相互作用。